Erika Hamilton/LinkedIn
Jun 7, 2025, 09:27
Erika Hamilton: I left ASCO25 with a full heart and an inspired mind
Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“I left ASCO25 with a full heart and an inspired mind.
Sarah Cannon Research Institute showed up in a big mission-driven way —we are transforming cancer care and personalizing treatment for those we serve. From clinical trial presentations and education sessions across gene therapy, blood cancers, lung cancer, melanoma, breast, phase I development, and more, the importance of community-based trials shined.
Presenting new data on vepdegestrant and emiltatug ledadotin reminded me just how far we’ve come in breast cancer research — but also how much further we still have to go — in designing smarter, safer, more personalized breast cancer therapies.
Thank you to the Sarah Cannon Research Institute team and the team at SCRI Oncology Partners, our peers, and the wider passionate community that came to our sessions, asked questions, and joined the conversation. Discover more about our presence at ASCO.”
Read OncoDaily’s Special Article: “Best of ASCO25 Annual Meeting”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 19:30
Jun 26, 2025, 17:54
Jun 26, 2025, 17:47